Martha Morrell compensation by year
NeuroPace Summary Compensation Table · all 6 fiscal years held| Component | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Salary | $397,975 | $435,679 | $453,000 | $468,502 | $486,702 | $489,842 |
| Bonus | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock awards | $0 | $188,305 | $381,094 | $380,000 | $213,875 | $140,634 |
| Option awards | $3,802 | $193,124 | $378,797 | $0 | $287,514 | $168,183 |
| Non-equity incentive | $82,205 | $147,825 | $102,538 | $260,174 | $181,460 | $235,473 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 | $0 | $0 |
| All other | $0 | $0 | $328 | $0 | $0 | $0 |
| Total | $483,982 | $964,933 | $1,315,757 | $1,108,676 | $1,169,551 | $1,034,132 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: NeuroPace Inc DEF 14A filed April 21, 2026, accession 0001140361-26-015894, and prior-year filings. Open the filing on EDGAR.
How this page was built: the NeuroPace Inc filed document, accession 0001140361-26-015894. Every figure is read from that document and cited to the page and table it appears in. Filed April 21, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 11,700 | $180,648 | — |
| RSU | 7,031 | $108,559 | — |
| RSU | 6,667 | $102,938 | — |
| RSU | 2,922 | $45,116 | — |
| RSU | 140,449 | $0 | — |
| Option | 5,846 | — | $8.15 |
| Option | 13,514 | — | $17.11 |
| Option | 19,850 | — | $12.02 |
Per the Outstanding Equity Awards at Fiscal Year-End table in NeuroPace Inc's FY2025 proxy; value at the fiscal year-end close, as the company printed it.
NeuroPace’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Joel Becker | President and Chief Executive Officer | $2,408,566 |
| Patrick Williams | Chief Financial Officer | $1,645,935 |
| Martha Morrell · this page | Chief Medical Officer | $1,034,132 |
| Rebecca Kuhn | Former Chief Financial Officer, Vice President, Finance and Administration | $846,308 |
Martha Morrell's compensation dossier, NeuroPace
You have read Martha Morrell's totals and holdings. The dossier adds each equity grant NeuroPace disclosed for Martha Morrell and NeuroPace's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.
See an example →The full NeuroPace compensation record
free company briefThis page is one person within NeuroPace's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order NeuroPace's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are NeuroPace's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order NPCE
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.